Tyra Biosciences Inc (TYRA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $33.18
• Market Cap: $1.81B
• EPS: $-1.88
• 52-Week High: $35.71
• 52-Week Low: $6.42

Market Sentiment

Tyra Biosciences Inc currently has a Bullish sentiment score of 0.36.

About Tyra Biosciences Inc

Tyra Biosciences, Inc. is a preclinical-stage biopharmaceutical firm headquartered in Carlsbad, California, dedicated to innovating targeted therapies that address tumor resistance mechanisms in cancer. By leveraging its proprietary drug discovery platform, Tyra aims to enhance therapeutic efficacy and patient outcomes in oncology. The company’s focus on the development of novel compounds positions it strategically within the competitive landscape of cancer therapeutics, aiming to deliver tra...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tyra Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TYRA pay dividends?

Tyra Biosciences Inc (TYRA) does not currently pay a regular dividend.

What is TYRA's market cap?

Tyra Biosciences Inc (TYRA) has a market capitalization of $1.81B with a current stock price of $33.18.